Lloyd Bod

967 total citations
6 papers, 189 citations indexed

About

Lloyd Bod is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Lloyd Bod has authored 6 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Lloyd Bod's work include Immune Cell Function and Interaction (3 papers), T-cell and B-cell Immunology (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Lloyd Bod is often cited by papers focused on Immune Cell Function and Interaction (3 papers), T-cell and B-cell Immunology (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Lloyd Bod collaborates with scholars based in United States, Japan and Israel. Lloyd Bod's co-authors include Vijay K. Kuchroo, Alexandra Schnell, Asaf Madi, Aviv Regev, Raymond A. Sobel, Linglin Huang, Monika S. Kowalczyk, Arlene H. Sharpe, Alina Bollhagen and Vasundhara Singh and has published in prestigious journals such as Nature Communications, Nature Immunology and The Journal of Immunology.

In The Last Decade

Lloyd Bod

5 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd Bod United States 4 130 99 40 17 11 6 189
Silvia Carnevale Italy 7 142 1.1× 78 0.8× 50 1.3× 15 0.9× 8 0.7× 7 197
Sandra S. Ring Switzerland 6 117 0.9× 107 1.1× 54 1.4× 28 1.6× 3 0.3× 8 220
Shamin Li United States 7 135 1.0× 83 0.8× 59 1.5× 6 0.4× 4 0.4× 12 196
Tyler G. Searles United States 5 148 1.1× 169 1.7× 53 1.3× 31 1.8× 4 0.4× 7 235
Joseph D. P. Willet United Kingdom 6 79 0.6× 36 0.4× 48 1.2× 11 0.6× 11 1.0× 7 146
Demi Brownlie United Kingdom 9 280 2.2× 164 1.7× 62 1.6× 12 0.7× 4 0.4× 10 330
Varintra E. Lander United States 5 117 0.9× 121 1.2× 79 2.0× 18 1.1× 17 1.5× 5 221
Katy A. Lloyd United States 8 178 1.4× 71 0.7× 84 2.1× 11 0.6× 10 0.9× 11 266
Susan McCanna United States 4 193 1.5× 188 1.9× 68 1.7× 17 1.0× 7 0.6× 11 280
Marjorie Mercier Belgium 4 227 1.7× 195 2.0× 23 0.6× 17 1.0× 13 1.2× 11 271

Countries citing papers authored by Lloyd Bod

Since Specialization
Citations

This map shows the geographic impact of Lloyd Bod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Bod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Bod more than expected).

Fields of papers citing papers by Lloyd Bod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Bod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Bod. The network helps show where Lloyd Bod may publish in the future.

Co-authorship network of co-authors of Lloyd Bod

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd Bod. A scholar is included among the top collaborators of Lloyd Bod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd Bod. Lloyd Bod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Liu, Xin, Zelong Liu, Chengzhan Zhu, et al.. (2025). Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma. Nature Communications. 16(1). 10416–10416.
2.
Messaoudene, Meriem, Stéphanie Ferreira, Caroline Truntzer, et al.. (2024). The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers. Nature Communications. 15(1). 8083–8083. 9 indexed citations
3.
Bod, Lloyd & Shabnam Shalapour. (2024). B cells spatial organization defines their phenotype and function in cancer “Tell me with whom you consort, and I will tell you who you are” ― Goethe. Current Opinion in Immunology. 91. 102504–102504. 1 indexed citations
4.
Schnell, Alexandra, Linglin Huang, Vasundhara Singh, et al.. (2023). Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation. Nature Immunology. 24(11). 1908–1920. 12 indexed citations
5.
Schnell, Alexandra, Lloyd Bod, Asaf Madi, & Vijay K. Kuchroo. (2020). The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity. Cell Research. 30(4). 285–299. 149 indexed citations
6.
Sungnak, Waradon, Allon Wagner, Monika S. Kowalczyk, et al.. (2020). T Follicular Regulatory Cell–Derived Fibrinogen-like Protein 2 Regulates Production of Autoantibodies and Induction of Systemic Autoimmunity. The Journal of Immunology. 205(12). 3247–3262. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026